Jing Li

机构：Wannan Medical College, Hebei Medical University, Ministry of Education of the People's Republic of China, Guangxi University, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming Medical University, Peking Union Medical College Hospital, Third Hospital of Hebei Medical University, National Clinical Research Center for Digestive Diseases, Hospital of Hebei Province, Second Hospital of Hebei Medical University, Shanxi Provincial Cancer Hospital, Hexi University, First Affiliated Hospital of Xi'an Jiaotong University, Shanghai Traditional Chinese Medicine Hospital · ORCID：0000-0003-2504-1629

发表论文 536 篇 · 总被引 10105 次 · h-index 45

代表论文

• First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 7)
• Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis (2025 · Annals of the Rheumatic Diseases · 被引 6)
• Advances and challenges in Toll-like receptor-targeted therapy for rheumatoid arthritis (2025 · Drug Discovery Today · 被引 3)
• A randomised study examining the utility of lauromacrogol foam sclerotherapy vs pingyangmycin in treatment of pediatric lymphatic malformations --a single center report from China (2025 · Journal of Pediatric Surgery · 被引 3)
• Elevated novel inflammatory markers in heart failure patients are associated with increased risk of adverse outcomes within one year: insights from a longitudinal study (2025 · Frontiers in Cardiovascular Medicine · 被引 3)
• Mycophenolate Mofetil versus Cyclophosphamide for Initial Therapy in Childhood-Onset Proliferative Lupus Nephritis (2025 · Journal of the American Society of Nephrology · 被引 3)